Real-time enrollment status for this masld - metabolic dysfunction-associated steatotic liver disease clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 9:15 PM UTC
| NCT Number | NCT07143968 |
| Recruiting Status | Recruiting |
| Condition | MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease |
| Phase | PHASE2 |
| Target Enrollment | 120 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Naga P. Chalasani |
| Last Updated on CT.gov | July 30, 2026 (4 weeks ago) |
As of August 27, 2026: Clinical trial NCT07143968 is currently recruiting participants. This phase2 study for masld - metabolic dysfunction-associated steatotic liver disease is actively seeking new participants at 10 locations across the United States. The study is sponsored by Naga P. Chalasani. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07143968 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07143968 was last updated 4 weeks ago (July 30, 2026). HelloStudys verifies this status automatically.